In 2021, OrACORe was appointed as the Coordinating Center for the Arthritis Foundation’s Osteoarthritis Clinical…
NEWS FEATURE ON OAPOL ANALYSIS OF THE COST-EFFECTIVENESS OF DULOXETINE + DEPRESSION SCREENING
An OAPol analysis published earlier this month in Arthritis Care & Research found that adding duloxetine to usual care for knee OA patients with moderate pain, regardless of depressive symptoms, is cost‐effective.
Click here for the coverage of these findings by Healio Rheumatology.
